

IN BRIEF: Arix Bioscience Closes Public Offering Of Shares


IN BRIEF: Arix Bioscience Says Sickle Cell Drug IMR-687 Well Tolerated


DIRECTOR DEALINGS: Arix Bioscience Chair Buys GBP377,000 In Shares


IN BRIEF: Arix Bioscience Shakes Off Virus To Post Promising Interim


IN BRIEF: Arix Bioscience Investee Plans LB-001 Trial After US FDA Ok


IN BRIEF: Arix Bioscience Notes Positive Data From Amplyx's Study


IN BRIEF: Arix's Atox To Submit Reltecimod Drug Application To US FDA


IN BRIEF: Arix's VelosBio Pockets USD137 Million In Fundraise